共 50 条
- [35] Cost-minimisation analysis of oritavancin for the treatment of acute bacterial skin and skin structure infections from a United Kingdom perspective EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2022, 23 (08): : 1371 - 1381
- [36] Cost-minimisation analysis of oritavancin for the treatment of acute bacterial skin and skin structure infections from a United Kingdom perspective The European Journal of Health Economics, 2022, 23 : 1371 - 1381
- [39] Newest lipoglycopeptides for the management of acute bacterial skin and skin structure infections NURSE PRACTITIONER, 2018, 43 (10): : 31 - 37